Ahwan Pandey

11PUBLICATIONS
196CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2026
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Dale Garsed, Tibor Zwimpfer, Sian Fereday

|Jul 24, 2025
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.

Lena Rai, Antonella Ravaggi, Eliana Bignotti

|Jul 18, 2024
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.

Nikki L Burdett, Madelynne O Willis, Ahwan Pandey

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

Pageof 2

Frequent Collaborators

9 joint publications

Dale W Garsed

9 joint publications

Elizabeth L Christie

7 joint publications

Sian Fereday

5 joint publications

Anna deFazio